Ambulatory blood pressure in chronic kidney disease

Current Hypertension Reports

Volumn 15, Issue 3, 2013, Pages 160-166

  Cohen, Debbie L ^a   Huan, Yonghong ^a   Townsend, Raymond R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

ABPM; Ambulatory blood pressure monitoring; Cardiovascular risk; Chronic kidney disease; CKD; Dipping; Hypertension; Reverse dipping

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CIRCADIAN RHYTHM; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; EVENING DOSAGE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; MORNING DOSAGE; PROGNOSIS; TREATMENT OUTCOME;

BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; HUMANS; HYPERTENSION; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84877813772     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-013-0339-2     Document Type: Article

References (36)

1. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073-81.
2. Systolic Blood Pressure Intervention Trial (SPRINT) http://SBPITScgcsNAJ. Accessed 30 Jan 2013.
3. •• Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D. Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008;52(1):1-9. A statement paper defining the uses of ABPM and providing data to encourage reimbursment for ABPM in various different population groups.
4. Millar-Craig MW, Bishop CN, Raftery EB. Circadian variation of blood-pressure. Lancet. 1978;1(8068):795-7.
5. Pickering TG, Harshfield GA, Kleinert HD, Blank S, Laragh JH. Blood pressure during normal daily activities, sleep, and exercise. Comparison of values in normal and hypertensive subjects. JAMA. 1982;247(7):992-6.
6. O'Brien E, Sheridan J, O'Malley K. Dippers and non-dippers. Lancet. 1988;2(8607):397.
7. O'Brien E, Murphy J, Tyndall A, Atkins N, Mee F, McCarthy G, et al. Twenty-four-hour ambulatory blood pressure in men and women aged 17 to 80 years: the Allied Irish Bank Study. J Hypertens. 1991;9(4):355-60.
8. Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, Cesana G, et al. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens. 1995;13(12 Pt 1):1377-90.
9. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens. 2002;20(11):2183-9.
10. Mailloux LU, Levey AS. Hypertension in patients with chronic renal disease. Am J Kidney Dis. 1998;32(5 Suppl 3):S120-41.
11. Buckalew Jr VM, Berg RL, Wang SR, Porush JG, Rauch S, Schulman G. Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. Am J Kidney Dis. 1996;28(6):811-21.
12. Portaluppi F, Montanari L, Ferlini M, Gilli P. Altered circadian rhythms of blood pressure and heart rate in non-hemodialysis chronic renal failure. Chronobiol Int. 1990;7(4):321-7.
13. Portaluppi F, Montanari L, Massari M, Di Chiara V, Capanna M. Loss of nocturnal decline of blood pressure in hypertension due to chronic renal failure. Am J Hypertens. 1991;4(1 Pt 1):20-6.
14. Farmer CK, Goldsmith DJ, Cox J, Dallyn P, Kingswood JC, Sharpstone P. An investigation of the effect of advancing uraemia, renal replacement therapy and renal transplantation on blood pressure diurnal variability. Nephrol Dial Transplant. 1997;12(11):2301-7.
15. Agarwal R, Kariyanna SS, Light RP. Prognostic value of circadian blood pressure variation in chronic kidney disease. Am J Nephrol. 2009;30(6):547-53.
16. • Mojón A, Ayala DE, Piñeiro L, Otero A, Crespo JJ, Moyá A, et al. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease. Chronobiol Int. 2013;30(1-2):145-58. This manuscript compares ABPM in hypertensive patients with and without CKD, and describes the altered circadian rhythm and differences in non-dipping and reverse dipping status in these populations.
17. • Mizuno M, Fukuda M, Miura T, Wakamatsu T, Naito T, Sato R, et al. Morning hypertension in chronic kidney disease is sustained type, but not surge type. Blood Press Monit. 2012;17(1):20-3. This manuscript describes ABPM findings observed in CKD patients with sustained nighttime BP readings that continue into the morning.
18. •• Minutolo R, Agarwal R, Borrelli S, Chiodini P, Bellizzi V, Nappi F, et al. Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med. 2011;171(12):1090-8. Large study of CKD patients comparing ABPM vs. office BP, showing better predictve value of ABPM for CV and renal progression.
19. Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Johansen K, et al. 'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis. 2012;59(1 Suppl 1):A7. e1-420.
20. Cohen DL, Townsend RR. Should patients with chronic kidney disease have an ambulatory BP monitor for accurate renal and cardiovascular risk assessment? J Clin Hypertens (Greenwich). 2011;13(11):861-2.
21. Agarwal R, Andersen MJ. Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease. Kidney Int. 2006;69(7):1175-80.
22. • Kanno A, Metoki H, Kikuya M, Terawaki H, Hara A, Hashimoto T, et al. Usefulness of assessing masked and white-coat hypertension by ambulatory blood pressure monitoring for determining prevalent risk of chronic kidney disease: the Ohasama study. Hypertens Res. 2010;33(11):1192-8. Study of ABPM in CKD patients that demonstrated a significant association between masked hypertension and white coat hypertension and CKD.
23. Wright Jr JT, Agodoa L, Contreras G, Greene T, Douglas JG, Lash J, et al. Successful blood pressure control in the African American Study of Kidney Disease and Hypertension. Arch Intern Med. 2002;162(14):1636-43.
24. Sika M, Lewis J, Douglas J, Erlinger T, Dowie D, Lipkowitz M, et al. Baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Clinical Trial and Cohort Study. Am J Kidney Dis. 2007;50(1):78-89. e1.
25. Pogue V, Rahman M, Lipkowitz M, Toto R, Miller E, Faulkner M, et al. Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension. 2009;53(1):20-7.
26. Cohen DL, Townsend RR. Masked hypertension: an increasingly common but often unrecognized issue in hypertension management. J Clin Hypertens (Greenwich). 2010;12(7):522-3.
27. •• Gabbai FB, Rahman M, Hu B, Appel LJ, Charleston J, Contreras G, et al. Relationship between Ambulatory BP and Clinical Outcomes in Patients with Hypertensive CKD. Clin J Am Soc Nephrol. 2012;7(11):1770-6. Study of hypertensive African American patients with CKD from AASK study who underwent ABPM that was more predictive of renal and CV outcomes than clinic BP measurements.
28. •• Boggia J, Thijs L, Li Y, Hansen TW, Kikuya M, Björklund-Bodegård K, et al. Risk stratification by 24-hour ambulatory blood pressure and estimated glomerular filtration rate in 5322 subjects from 11 populations. Hypertension. 2013;61(1):18-26. Study that demonstrated estimated GFR is additive to ABPM in predicting CV risk in patients with CKD.
29. Thijs L, Hansen TW, Kikuya M, Bjorklund-Bodegard K, Li Y, Dolan E, et al. The International Database of Ambulatory Blood Pressure in relation to Cardiovascular Outcome (IDACO): protocol and research perspectives. Blood Press Monit. 2007;12(4):255-62.
30. Agarwal R, Andersen MJ. Blood pressure recordings within and outside the clinic and cardiovascular events in chronic kidney disease. Am J Nephrol. 2006;26(5):503-10.
31. Hermida RC, Ayala DE, Mojon A, Fernandez JR. Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD. J Am Soc Nephrol. 2011;22(12):2313-21.
32. • Wuhl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, et al. Strict blood-pressure control and progression of renal failure in children. N Engl J Med. 2009;361(17):1639-50. Study in pediatric patients with CKD using ABPM to adjust medication to achieve BP goal to predict renal progression.
33. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med. 2006;354(22):2368-74.
34. Rubin MF, Brunelli SM, Townsend RR. Variability-the drama of the circulation. J Clin Hypertens (Greenwich). 2010;12(4):284-7.
35. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 2003;348(24):2407-15.
36. Feldman HI, Appel LJ, Chertow GM, Cifelli D, Cizman B, Daugirdas J, et al. The Chronic Renal Insufficiency Cohort (CRIC) study: design and methods. J Am Soc Nephrol. 2003;14(7 Suppl 2):S148-53.